Ocera Therapeutics - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥748,257.36 -3.19%
以太坊 ¥17,959.71 -3.53%
币安币 ¥4,627.25 -1.35%
Optimism ¥3.98 -8.63%
Arbitrum ¥2.16 -9.09%
Solana ¥1,052.38 -5.24%
Polygon ¥1.56 +2.77%
Cosmos ¥28.87 -4.90%
Avalanche ¥131.76 -6.03%

比特币 ¥748,257.36 -3.19%
以太坊 ¥17,959.71 -3.53%
币安币 ¥4,627.25 -1.35%
Optimism ¥3.98 -8.63%
Arbitrum ¥2.16 -9.09%
Solana ¥1,052.38 -5.24%
Polygon ¥1.56 +2.77%
Cosmos ¥28.87 -4.90%
Avalanche ¥131.76 -6.03%

Ocera Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

2

20

Ocera Therapeutics is funded by 20 investors. Sofinnova Investments and Greenspring Associates are the most recent investors.

Investor Name	Lead Investor	Funding Round
Sofinnova Investments	Yes	Series B
Greenspring Associates	-	Post-IPO Debt
Oxford Finance LLC	-	Post-IPO Debt
Silicon Valley Bank	-	Post-IPO Debt
Deerfield Partners	-	Post-IPO Equity
Great Point Partners	-	Post-IPO Equity
InterWest Partners	-	Post-IPO Equity
QVT Financial	-	Post-IPO Equity
RA Capital Management	-	Post-IPO Equity
Three Arch Partners	-	Post-IPO Equity
Venrock	-	Post-IPO Equity
Vivo Capital	-	Post-IPO Equity
AgeChem Venture Fund	-	Series C
CDIB BioScience Ventures	-	Series C
Cross Creek	-	Series C
Domain Associates	-	Series C
FinTech Innovation Lab	-	Series C
Sofinnova Partners	-	Series C
Thomas, McNerney & Partners	-	Series C
Wasatch Advisors	-	Series C